NCT07253974 Prospective Evaluation of Atrial Fibrillation-Related Stroke Patients in Rehabilitation Program (PEARL), an Observational Cohort Study
| NCT ID | NCT07253974 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Parc de Salut Mar |
| Condition | STROKE |
| Study Type | OBSERVATIONAL |
| Enrollment | 213 participants |
| Start Date | 2024-11-11 |
| Primary Completion | 2026-11-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 213 participants in total. It began in 2024-11-11 with a primary completion date of 2026-11-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to determine if rehabilitation program intensity impacts functional recovery and specific needs in adult ischemic stroke patients who require inpatient rehabilitation. The main questions it aims to answer are: Do patients with stroke of Atrial-related subtypes (AFRS) have distinct rehabilitation needs and functional outcomes compared to non-AFRS patients? Does higher-intensity inpatient rehabilitation (3-5 sessions/day) result in better functional recovery at six months (measured by the Barthel Index) than moderate-intensity programs (1 session/day)? The study is non-invasive, does not interfere with usual care. The investigators' ultimate goal is to enhance the understanding of recovery after following different rehabilitation usual programs.
Eligibility Criteria
Inclusion Criteria:\> 18 a, first-ever intracerebral ischemic stroke \- Exclusion Criteria: * intracranial haemorrhage, symptomatic hemorrhagic transformation, new infarcts after the initial stroke or other neurological or psychiatric conditions.
Contact & Investigator
Anna Guillen-Sola, MD, PHd
PRINCIPAL INVESTIGATOR
Research Rehabilitation Group, IMIM
Frequently Asked Questions
Who can join the NCT07253974 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying STROKE. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07253974 currently recruiting?
Yes, NCT07253974 is actively recruiting participants. Contact the research team at aguillen@hmar.cat for enrollment information.
Where is the NCT07253974 trial being conducted?
This trial is being conducted at Barcelona, Spain.
Who is sponsoring the NCT07253974 clinical trial?
NCT07253974 is sponsored by Parc de Salut Mar. The principal investigator is Anna Guillen-Sola, MD, PHd at Research Rehabilitation Group, IMIM. The trial plans to enroll 213 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.